Log In
BCIQ
Print this Print this
 

PAN-22

  Manage Alerts
Collapse Summary General Information
Company Panacea Pharmaceuticals Inc.
DescriptionHuman anti-aspartate beta-hydroxylase (HAAH) mAb
Molecular Target Aspartate beta-hydroxylase (ASPH) (HAAH)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today